FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056559030> ?p ?o ?g. }

• W2056559030 endingPage "75" @default.
• W2056559030 startingPage "68" @default.
• W2056559030 abstract "In patients with locally advanced cervical cancer, most of the treatment failures occur within the pelvis. In an attempt to improve local control, 40 patients with bulky tumors (stage IB > 5 era, stage IIB with distal parametrial invasion, and stage III-IVA) were treated between 1988 and 1992 with concurrent chemoradiation (CCR). The whole pelvis received a midplane dose of 45 Gy over 33 days. Daily radiation dose was 1.8 Gy, with twice-daily fractionation in the last 20 patients. Chemotherapy was administered on the 1st and 21st days of radiation therapy (RT) consisting of cisplatin (60 mg/m2), followed by 5-fluorouracil (600 mg/m2/day continuous iv infusion) over 96 hr (and decreased to 40 and 400 mg/m2, respectively, in the last 23 patients). CCR was first followed by a single intracavitary application and then by a parametrial boost in stage IIB-III patients and in stage IVA patients with disease reaching the pelvis side wall. Then surgery (colpohysterectomy with lymphadenectomy or pelvic exenteration) was performed in 35 patients. Median follow-up time was 2.6 years (0.6-5.6 years). Acute toxicity (WHO grade 3-4 diarrhea) in 13 patients led to 6 RT interruptions and 4 incomplete RTs. One patient died of a septic episode without leukopenia after completion of CCR. Five postexenteration complications required a second surgical procedure, of which one patient died with tumor and small bowel fistula. One patient developed small bowel late complication and another patient developed urinary late complications. No postoperative or late complications were observed in patients treated with twice-daily fractionation. Pelvic control was achieved in 32 of 40 patients (81 and 74% in stage IB-IIB and stage III-IVA, respectively). Sites of failure were the pelvis (6 cases), metastases (7 cases), and both (2 cases). Two-year survival and DFS rates were 61 and 66%, respectively, in stage IB-IIB and 77 and 65% in stage III-IVA. High SCC-TA4 values significantly worsened DFS rates. In patients with stage III-IVA tumors, additional surgery could be an important component of this treatment strategy and may be compatible with CCR using twice-daily fractionation radiotherapy. However, these results must be confirmed by a large-scale prospective study." @default.
• W2056559030 created "2016-06-24" @default.
• W2056559030 creator A5009364522 @default.
• W2056559030 creator A5013846365 @default.
• W2056559030 creator A5020758672 @default.
• W2056559030 creator A5024714173 @default.
• W2056559030 creator A5042869289 @default.
• W2056559030 creator A5044846925 @default.
• W2056559030 creator A5053494419 @default.
• W2056559030 creator A5069748601 @default.
• W2056559030 creator A5081081344 @default.
• W2056559030 creator A5082556359 @default.
• W2056559030 date "1994-07-01" @default.
• W2056559030 modified "2023-10-16" @default.
• W2056559030 title "Concomitant Chemoradiation prior to Surgery in the Treatment of Advanced Cervical Carcinoma" @default.
• W2056559030 doi "https://doi.org/10.1006/gyno.1994.1168" @default.
• W2056559030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8020842" @default.
• W2056559030 hasPublicationYear "1994" @default.
• W2056559030 type Work @default.
• W2056559030 sameAs 2056559030 @default.
• W2056559030 citedByCount "68" @default.
• W2056559030 countsByYear W20565590302012 @default.
• W2056559030 countsByYear W20565590302013 @default.
• W2056559030 countsByYear W20565590302015 @default.
• W2056559030 countsByYear W20565590302016 @default.
• W2056559030 countsByYear W20565590302018 @default.
• W2056559030 countsByYear W20565590302021 @default.
• W2056559030 countsByYear W20565590302022 @default.
• W2056559030 crossrefType "journal-article" @default.
• W2056559030 hasAuthorship W2056559030A5009364522 @default.
• W2056559030 hasAuthorship W2056559030A5013846365 @default.
• W2056559030 hasAuthorship W2056559030A5020758672 @default.
• W2056559030 hasAuthorship W2056559030A5024714173 @default.
• W2056559030 hasAuthorship W2056559030A5042869289 @default.
• W2056559030 hasAuthorship W2056559030A5044846925 @default.
• W2056559030 hasAuthorship W2056559030A5053494419 @default.
• W2056559030 hasAuthorship W2056559030A5069748601 @default.
• W2056559030 hasAuthorship W2056559030A5081081344 @default.
• W2056559030 hasAuthorship W2056559030A5082556359 @default.
• W2056559030 hasConcept C121608353 @default.
• W2056559030 hasConcept C126322002 @default.
• W2056559030 hasConcept C141071460 @default.
• W2056559030 hasConcept C146357865 @default.
• W2056559030 hasConcept C151730666 @default.
• W2056559030 hasConcept C2776694085 @default.
• W2056559030 hasConcept C2778220009 @default.
• W2056559030 hasConcept C2779384505 @default.
• W2056559030 hasConcept C2780873365 @default.
• W2056559030 hasConcept C509974204 @default.
• W2056559030 hasConcept C71924100 @default.
• W2056559030 hasConcept C86803240 @default.
• W2056559030 hasConceptScore W2056559030C121608353 @default.
• W2056559030 hasConceptScore W2056559030C126322002 @default.
• W2056559030 hasConceptScore W2056559030C141071460 @default.
• W2056559030 hasConceptScore W2056559030C146357865 @default.
• W2056559030 hasConceptScore W2056559030C151730666 @default.
• W2056559030 hasConceptScore W2056559030C2776694085 @default.
• W2056559030 hasConceptScore W2056559030C2778220009 @default.
• W2056559030 hasConceptScore W2056559030C2779384505 @default.
• W2056559030 hasConceptScore W2056559030C2780873365 @default.
• W2056559030 hasConceptScore W2056559030C509974204 @default.
• W2056559030 hasConceptScore W2056559030C71924100 @default.
• W2056559030 hasConceptScore W2056559030C86803240 @default.
• W2056559030 hasIssue "1" @default.
• W2056559030 hasLocation W20565590301 @default.
• W2056559030 hasLocation W20565590302 @default.
• W2056559030 hasOpenAccess W2056559030 @default.
• W2056559030 hasPrimaryLocation W20565590301 @default.
• W2056559030 hasRelatedWork W1448091729 @default.
• W2056559030 hasRelatedWork W1511187821 @default.
• W2056559030 hasRelatedWork W2357273538 @default.
• W2056559030 hasRelatedWork W2361544313 @default.
• W2056559030 hasRelatedWork W2367148332 @default.
• W2056559030 hasRelatedWork W2380330452 @default.
• W2056559030 hasRelatedWork W2392383546 @default.
• W2056559030 hasRelatedWork W2419081241 @default.
• W2056559030 hasRelatedWork W2607777675 @default.
• W2056559030 hasRelatedWork W3149210031 @default.
• W2056559030 hasVolume "54" @default.
• W2056559030 isParatext "false" @default.
• W2056559030 isRetracted "false" @default.
• W2056559030 magId "2056559030" @default.
• W2056559030 workType "article" @default.